Article

CURE's Top 5 Stories: May 2018

Take a look at the top five CURE stories of May 2018 in this video.

Here are the top 5 CURE stories for May 2018.

5. Surveillance of Survivors Can Save Lives

Second cancers are common among patients with lung cancer. We explore the risk factors and how they can be avoided in this piece, featured in our CURE Special Issue on Lung Cancer.

4. My New Normal Isn’t Quite So New Anymore

In this piece, CURE contributor Bonnie Annis explains how redefining “normal” is a vital part of a cancer survivor's post diagnosis timeline.

3. How to Talk to Kids About Cancer

CURE sat down with a childhood development specialist and a colorectal cancer survivor who offered firsthand advice on how to discuss a cancer diagnosis with children of any age.

2. The Special Relationship with My Oncologist

After years of distrust, CURE contributor Jane Biehl recalls how finding the right oncologist was like striking gold.

1. Mental Health Awareness Following a Cancer Diagnosis

With Mental Health Awareness Month coming to a close, this blog explores how openly discussing post-diagnosis mental health changes can improve mind and body wellness.

And in related news, CURE Media Group hosted two events at the Oncology Nursing Society’s 43rd Annual Congress in Washington, D.C.

On May 17th, Christine Stone was selected as this year’s recipient of the Extraordinary Healer Award for Oncology Nursing, and the first-ever Bone Health Champions gala was held on May 18th. Both events honored oncology nurses who have committed themselves to educating patients, raising awareness and making advancements in their fields.

For recaps on these events, along with all of our top stories, visit curetoday.com.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Related Content